Precision BioSciences Statistics Share Statistics Precision BioSciences has 11.79M
shares outstanding. The number of shares has increased by 53.63%
in one year.
Shares Outstanding 11.79M Shares Change (YoY) 53.63% Shares Change (QoQ) 6.02% Owned by Institutions (%) 40.75% Shares Floating 10.55M Failed to Deliver (FTD) Shares 49 FTD / Avg. Volume 0.04%
Short Selling Information The latest short interest is 1.16M, so 9.82% of the outstanding
shares have been sold short.
Short Interest 1.16M Short % of Shares Out 9.82% Short % of Float 10.12% Short Ratio (days to cover) 13.07
Valuation Ratios The PE ratio is 3.63 and the forward
PE ratio is -1.43.
Precision BioSciences's PEG ratio is
-0.03.
PE Ratio 3.63 Forward PE -1.43 PS Ratio 0.38 Forward PS 3.1 PB Ratio 0.46 P/FCF Ratio -0.44 PEG Ratio -0.03
Financial Ratio History Enterprise Valuation Precision BioSciences has an Enterprise Value (EV) of -29.82M.
EV / Sales -0.43 EV / EBITDA -2.2 EV / EBIT 0.51 EV / FCF 0.51
Financial Position The company has a current ratio of 6.34,
with a Debt / Equity ratio of 0.53.
Current Ratio 6.34 Quick Ratio 6.34 Debt / Equity 0.53 Debt / EBITDA 2.22 Debt / FCF -0.51 Interest Coverage -14.68
Financial Efficiency Return on Equity is 12.71% and Return on Invested Capital is -21.09%.
Return on Equity 12.71% Return on Assets 5.25% Return on Invested Capital -21.09% Revenue Per Employee $636.07K Profits Per Employee $66.36K Employee Count 108 Asset Turnover 0.5 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -44.09% in the
last 52 weeks. The beta is 1.61, so Precision BioSciences's
price volatility has been higher than the market average.
Beta 1.61 52-Week Price Change -44.09% 50-Day Moving Average 4.84 200-Day Moving Average 4.93 Relative Strength Index (RSI) 55.15 Average Volume (20 Days) 133,901
Income Statement In the last 12 months, Precision BioSciences had revenue of 68.7M
and earned 7.17M
in profits. Earnings per share was 1.05.
Revenue 68.7M Gross Profit 68.7M Operating Income -26.16M Net Income 7.17M EBITDA 13.53M EBIT 8.95M Earnings Per Share (EPS) 1.05
Full Income Statement Balance Sheet The company has 85.9M in cash and 30.05M in
debt, giving a net cash position of 55.85M.
Cash & Cash Equivalents 85.9M Total Debt 30.05M Net Cash 55.85M Retained Earnings -482.46M Total Assets 108.93M Working Capital 56.69M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -58.45M
and capital expenditures -250K, giving a free cash flow of -58.7M.
Operating Cash Flow -58.45M Capital Expenditures -250K Free Cash Flow -58.7M FCF Per Share -8.59
Full Cash Flow Statement Margins Gross margin is 100%, with operating and profit margins of -38.08% and 10.43%.
Gross Margin 100% Operating Margin -38.08% Pretax Margin 10.43% Profit Margin 10.43% EBITDA Margin 19.69% EBIT Margin -38.08% FCF Margin -85.44%
Dividends & Yields DTIL does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 27.53% FCF Yield -225.46%
Dividend Details Analyst Forecast The average price target for DTIL is $47,
which is 828.9% higher than the current price. The consensus rating is "Buy".
Price Target $47 Price Target Difference 828.9% Analyst Consensus Buy Analyst Count 2
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number 13.96 Graham Upside 175.89%
Stock Splits The last stock split was on Feb 14, 2024. It was a
backward
split with a ratio of 1:30.
Last Split Date Feb 14, 2024 Split Type backward Split Ratio 1:30
Scores Altman Z-Score -7.99 Piotroski F-Score 2
